Business Wire
-
Molecular Instruments Announces HCR Gold IF For Multiplex Protein Imaging On Biocare Medical's ONCORE Pro X
9/8/2026
Molecular Instruments(MI), founded by the inventor of HCR technology, today announced the availability of HCR Gold IF on Biocare Medical’s ONCORE Pro X, a fully open automated slide staining system for research laboratories.
-
Agilent Expands Digital Pathology Offering With U.S. Launch Of The Agilent S540MD Slide Scanner System
9/4/2026
Agilent Technologies Inc. today announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, following FDA clearance.
-
Thermo Fisher Scientific Launches Multiskan Ease Absorbance Microplate Reader To Help Simplify Protein, Cell And Microbial Analysis
9/2/2026
Thermo Fisher Scientific today announced the launch of the Thermo Scientific Multiskan Ease Absorbance Microplate Reader, designed to support protein quantification, enzyme-linked immunosorbent assays (ELISAs), cell viability studies, microbial growth monitoring and other routine laboratory applications with simplified operation and dependable performance.
-
Invivoscribe Begins Commercial Shipments Of PrepQuant Systems, Enabling High-Sensitivity Sample Preparation For MRD Testing
9/2/2026
Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced that commercial shipments of the PrepQuant System have begun in North America.
-
Agilent Introduces The Cary 635 FTIR Spectrometer
9/1/2026
Agilent Technologies, Inc. today announced the launch of the Agilent Cary 635 FTIR spectrometer, setting a new standard for compact, high-performance Fourier transform infrared (FTIR) analysis.
-
QIAGEN Launches QIAsymphony Connect For Automated Clinical Nucleic Acid Extraction
8/27/2026
QIAGEN N.V. today announced the commercial launch of QIAsymphony Connect, an IVD-compliant platform for automated clinical nucleic acid extraction.
-
Ataraxis AI's Laboratory Receives CAP Accreditation And California Clinical Laboratory License
8/25/2026
Ataraxis AI, a frontier clinical artificial intelligence (AI) company developing AI-powered tools for oncology, today announced that its laboratory has received accreditation from the College of American Pathologists (CAP) and a clinical laboratory license from the State of California, expanding access to the Ataraxis Breast platform for clinicians and patients across the state.
-
Thermo Fisher Scientific Launches First Orbitrap Mass Spectrometers For Isotope Ratio Analysis, Enabling More Labs To Decode The Story Behind A Sample
8/25/2026
Thermo Fisher Scientific, the world leader in serving science, today introduced the Thermo Scientific Orbitrap Isora Mass Spectrometer and Orbitrap Isora Pro Mass Spectrometer, the company’s first Orbitrap instruments with a dedicated isotope ratio analysis mode.
-
FDA Clears C2N Diagnostics' PrecivityAD2 — First Alzheimer's Blood Test For Adults With Cognitive Symptoms As Young As 40
8/20/2026
The U.S. Food & Drug Administration (FDA) has cleared C2N Diagnostics’ PrecivityAD2 test, providing patients and health care professionals with an accurate, accessible, and scalable blood test to help diagnose Alzheimer’s disease in conjunction with standard clinical workup.
-
Cardio Diagnostics Begins In-House Test Processing At Its New High Complexity CLIA-Certified Laboratory In Iowa City
8/18/2026
Cardio Diagnostics Holdings, Inc., an AI-driven precision cardiovascular medicine company, today announced the official launch of its in-house, high complexity CLIA-certified laboratory in Iowa City, Iowa.